Pfizer And AstraZeneca Prove To Be More Than 90% Effective Against Delta Variant

Analysis of the Public Health England stated that Pfizer is 96% effective and AstraZeneca is 92% effective against hospitalisation from the Delta variant of COVID-19 on June 14. They also stated the necessity of getting the second dose on time for the complete effectiveness of the vaccines. These percentages are comparable with vaccine effectiveness against hospitalisation from the Alpha variant, which was first identified in the UK.